Article

Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort Study

2023-11-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Repeated population-based SARS-CoV-2 serosurveillance is key in complementing other surveillance tools. <h4>Aim</h4> Assessing trends in infection- and/or vaccine-induced immunity, including breakthrough infections, among (sub)groups and regions in the Dutch population during the Variant of Concern (VOC)-era whilst varying levels of stringency, to evaluate population immunity...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9e49449b-4c99-5238-810b-24311a6b4987
DOI: 10.1101/2023.11.22.23298889

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Nationwide SARS-CoV-2 Seroprevalence Trends in the Netherlands in the Variant of Concern Era, 2021-2022: an Ongoing Prospective Cohort StudyDOI 10.1101/2023.11.22.23298889Read

Prevalence of SARS-CoV-2 antibodies and associated factors in the adult population of Belgium: a general population cohort study between March 2021 and April 2022Semantic proximity Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read

Seroprevalence of SARS-CoV-2 antibodies prior to the widespread introduction of vaccine programmes in the WHO European Region, January - December 2020: a systematic reviewSemantic proximity Read

Seroincidence of SARS-CoV-2 infection prior to and during the rollout of vaccines in a community-based prospective cohort of U.S. adultsSemantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read

First “snap-shot” meta-analysis to estimate the prevalence of serum antibodies to SARS-CoV-2 in humansSemantic proximity Read

Global SARS-CoV-2 seroprevalence: a systematic review and meta-analysis of standardized population-based studies from Jan 2020-May 2022Semantic proximity Read

The prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upSemantic proximity Read

Reconstructing the force of infection and immune fraction of the population via a single snapshot survey: a case study of COVID-19 in JapanSemantic proximity Read

Epidemiological characteristics of three SARS-CoV-2 variants of concern and implications for future COVID-19 pandemic outcomesSemantic proximity Read

The potential impact of Omicron and future variants of concern on SARS-CoV-2 transmission dynamics and public health burden: a modelling studySemantic proximity Read

Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021Semantic proximity Read